{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T02:40:21Z","timestamp":1791945621552,"version":"4.3.4"},"reference-count":107,"publisher":"European Respiratory Society (ERS)","issue":"159","license":[{"start":{"date-parts":[[2021,1,19]],"date-time":"2021-01-19T00:00:00Z","timestamp":1611014400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["publications.ersnet.org"],"crossmark-restriction":true},"short-container-title":["Eur Respir Rev"],"accepted":{"date-parts":[[2020,10,27]]},"published-print":{"date-parts":[[2021,3,31]]},"abstract":"<jats:p>Malignant pleural mesothelioma is an aggressive, incurable cancer that is usually caused by asbestos exposure several decades before symptoms arise. Despite widespread prohibition of asbestos production and supply, its incidence continues to increase. It is heterogeneous in its presentation and behaviour, and diagnosis can be notoriously difficult. Identification of actionable gene mutations has proven challenging and current treatment options are largely ineffective, with a median survival of 10\u201312\u2005months.<\/jats:p>\n                  <jats:p>However, the past few years have witnessed major advances in our understanding of the biology and pathogenesis of mesothelioma. This has also revealed the limitations of existing diagnostic algorithms and identified new treatment targets.<\/jats:p>\n                  <jats:p>Recent clinical trials have re-examined the role of surgery, provided new options for the management of associated pleural effusions and heralded the addition of targeted therapies. The increasing complexity of mesothelioma management, along with a desperate need for further research, means that a multidisciplinary team framework is essential for the delivery of contemporary mesothelioma care.<\/jats:p>\n                  <jats:p>This review provides a synthesised overview of the current state of knowledge and an update on the latest research in the field.<\/jats:p>","DOI":"10.1183\/16000617.0226-2020","type":"journal-article","created":{"date-parts":[[2021,1,20]],"date-time":"2021-01-20T04:10:20Z","timestamp":1611115820000},"page":"200226","update-policy":"https:\/\/doi.org\/10.1183\/ers-crossmark-policy","source":"Crossref","is-referenced-by-count":66,"title":["Update on biology and management of mesothelioma"],"prefix":"10.1183","volume":"30","author":[{"given":"Rachelle","family":"Asciak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6292-5875","authenticated-orcid":false,"given":"Vineeth","family":"George","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Najiib M.","family":"Rahman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"81","published-online":{"date-parts":[[2021,1,19]]},"reference":[{"key":"2024102403515610000_30.159.200226.1","unstructured":"Royal College of Physicians (RCP) . National Mesothelioma Audit report 2018 (audit period 2014\u201316). London, RCP, 2018. www.rcplondon.ac.uk\/projects\/outputs\/national-mesothelioma-audit-report-2018-audit-period-2014-16 Date last accessed: June 30, 2018."},{"key":"2024102403515610000_30.159.200226.2","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0063-2016"},{"key":"2024102403515610000_30.159.200226.3","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2559.1997.5460776.x"},{"key":"2024102403515610000_30.159.200226.4","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jss.2015.01.043","article-title":"Impact of mesothelioma histologic subtype on outcomes in the Surveillance, Epidemiology, and End Results database","volume":"196","author":"Meyerhoff","year":"2015","journal-title":"J Surg Res"},{"key":"2024102403515610000_30.159.200226.5","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2003.11.136"},{"key":"2024102403515610000_30.159.200226.6","doi-asserted-by":"publisher","DOI":"10.1097\/JTO.0b013e31817c73d6"},{"key":"2024102403515610000_30.159.200226.7","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)01238-6"},{"key":"2024102403515610000_30.159.200226.8","first-page":"260","article-title":"Diffuse pleural mesothelioma and asbestos exposure in the North Western Cape Province","volume":"17","author":"Wagner","year":"1960","journal-title":"Br J Ind Med"},{"key":"2024102403515610000_30.159.200226.9","doi-asserted-by":"publisher","DOI":"10.1136\/oem.56.8.505"},{"key":"2024102403515610000_30.159.200226.10","doi-asserted-by":"publisher","DOI":"10.1183\/09059180.00007014"},{"key":"2024102403515610000_30.159.200226.11","first-page":"2263","article-title":"Cigarette smoking, asbestos exposure, and malignant mesothelioma","volume":"51","author":"Muscat","year":"1991","journal-title":"Cancer Res"},{"key":"2024102403515610000_30.159.200226.12","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2017-211321"},{"key":"2024102403515610000_30.159.200226.13","doi-asserted-by":"crossref","first-page":"82","DOI":"10.4103\/0019-5278.146897","article-title":"Global mesothelioma epidemic: trend and features","volume":"18","author":"Bianchi","year":"2014","journal-title":"Indian J Occup Environ Med"},{"key":"2024102403515610000_30.159.200226.14","doi-asserted-by":"publisher","DOI":"10.1016\/S0093-7754(02)70081-X"},{"key":"2024102403515610000_30.159.200226.15","doi-asserted-by":"publisher","DOI":"10.1016\/0959-8049(95)00365-P"},{"key":"2024102403515610000_30.159.200226.16","doi-asserted-by":"publisher","DOI":"10.1136\/oemed-2015-103074"},{"key":"2024102403515610000_30.159.200226.17","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/j.1749-6632.1991.tb24446.x","article-title":"Comparative dose\u2013response relationships of asbestos fiber types: magnitudes and uncertainties","volume":"643","author":"Nicholson","year":"1991","journal-title":"Ann NY Acad Sci"},{"key":"2024102403515610000_30.159.200226.18","doi-asserted-by":"publisher","DOI":"10.1093\/annhyg\/38.4.625"},{"key":"2024102403515610000_30.159.200226.19","doi-asserted-by":"crossref","first-page":"543","DOI":"10.21037\/tlcr.2018.07.05","article-title":"The eighth TNM classification for malignant pleural mesothelioma","volume":"7","author":"Berzenji","year":"2018","journal-title":"Transl Lung Cancer Res"},{"key":"2024102403515610000_30.159.200226.20","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.170207097"},{"key":"2024102403515610000_30.159.200226.21","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0604008103"},{"key":"2024102403515610000_30.159.200226.22","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/bgt166"},{"key":"2024102403515610000_30.159.200226.23","doi-asserted-by":"publisher","DOI":"10.1007\/s12199-007-0015-8"},{"key":"2024102403515610000_30.159.200226.24","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1006542107"},{"key":"2024102403515610000_30.159.200226.25","doi-asserted-by":"crossref","first-page":"262","DOI":"10.5858\/arpa.2011-0039-RA","article-title":"Mesothelioma not associated with asbestos exposure","volume":"136","author":"Jasani","year":"2012","journal-title":"Arch Pathol Lab Med"},{"key":"2024102403515610000_30.159.200226.26","doi-asserted-by":"publisher","DOI":"10.1002\/mpo.2950090409"},{"key":"2024102403515610000_30.159.200226.27","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-4652(199908)180:2<167::AID-JCP4>3.0.CO;2-Q"},{"key":"2024102403515610000_30.159.200226.28","first-page":"4745","article-title":"Oral polio vaccine and human cancer: a reassessment of SV40 as a contaminant based upon legal documents","volume":"20","author":"Kops","year":"2000","journal-title":"Anticancer Res"},{"key":"2024102403515610000_30.159.200226.29","first-page":"1781","article-title":"Simian virus 40-like DNA sequences in human pleural mesothelioma","volume":"9","author":"Carbone","year":"1994","journal-title":"Oncogene"},{"key":"2024102403515610000_30.159.200226.30","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-9896(199803)184:3<252::AID-PATH15>3.0.CO;2-R"},{"key":"2024102403515610000_30.159.200226.31","doi-asserted-by":"crossref","first-page":"670","DOI":"10.3389\/fonc.2019.00670","article-title":"Association between simian virus 40 and human tumors","volume":"9","author":"Rotondo","year":"2019","journal-title":"Front Oncol"},{"key":"2024102403515610000_30.159.200226.32","first-page":"4505","article-title":"A multi-institutional study confirms the presence and expression of simian virus 40 in human malignant mesotheliomas","volume":"58","author":"Testa","year":"1998","journal-title":"Cancer Res"},{"key":"2024102403515610000_30.159.200226.33","first-page":"1524","article-title":"SV40 induces mesotheliomas in hamsters","volume":"142","author":"Cicala","year":"1993","journal-title":"Am J Pathol"},{"key":"2024102403515610000_30.159.200226.34","doi-asserted-by":"publisher","DOI":"10.1002\/jcb.10058"},{"key":"2024102403515610000_30.159.200226.35","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1098-2744(199910)26:2<93::AID-MC4>3.0.CO;2-Z"},{"key":"2024102403515610000_30.159.200226.36","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(04)17102-X"},{"key":"2024102403515610000_30.159.200226.37","doi-asserted-by":"publisher","DOI":"10.1093\/ajcp\/86.2.227"},{"key":"2024102403515610000_30.159.200226.38","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0142(19960401)77:7<1379::AID-CNCR24>3.0.CO;2-Y"},{"key":"2024102403515610000_30.159.200226.39","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.22526"},{"key":"2024102403515610000_30.159.200226.40","doi-asserted-by":"publisher","DOI":"10.1136\/thx.33.2.181"},{"key":"2024102403515610000_30.159.200226.41","doi-asserted-by":"publisher","DOI":"10.1126\/science.7071597"},{"key":"2024102403515610000_30.159.200226.42","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)04013-7"},{"key":"2024102403515610000_30.159.200226.43","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1985.108"},{"key":"2024102403515610000_30.159.200226.44","doi-asserted-by":"crossref","first-page":"2863","DOI":"10.1200\/JCO.2018.78.5204","article-title":"Frequency of germline mutations in cancer susceptibility genes in malignant mesothelioma","volume":"36","author":"Panou","year":"2018","journal-title":"J Clin Oncol"},{"key":"2024102403515610000_30.159.200226.45","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1097\/JTO.0000000000000466","article-title":"Recent insights emerging from malignant mesothelioma genome sequencing","volume":"10","author":"Carbone","year":"2015","journal-title":"J Thorac Oncol"},{"key":"2024102403515610000_30.159.200226.46","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-14-1008"},{"key":"2024102403515610000_30.159.200226.47","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1111\/cas.12769","article-title":"Deletion status of p16 in effusion smear preparation correlates with that of underlying malignant pleural mesothelioma tissue","volume":"106","author":"Hida","year":"2015","journal-title":"Cancer Sci"},{"key":"2024102403515610000_30.159.200226.48","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-18-0804"},{"key":"2024102403515610000_30.159.200226.49","doi-asserted-by":"publisher","DOI":"10.1097\/JTO.0000000000000436"},{"key":"2024102403515610000_30.159.200226.50","doi-asserted-by":"publisher","DOI":"10.1038\/nm.4333"},{"key":"2024102403515610000_30.159.200226.51","first-page":"2610","article-title":"p53 and Kirsten-ras mutations in human mesothelioma cell lines","volume":"52","author":"Metcalf","year":"1992","journal-title":"Cancer Res"},{"key":"2024102403515610000_30.159.200226.52","doi-asserted-by":"crossref","first-page":"e72303","DOI":"10.1371\/journal.pone.0072303","article-title":"Dynamics of DNA damage induced pathways to cancer","volume":"8","author":"Tian","year":"2013","journal-title":"PLoS One"},{"key":"2024102403515610000_30.159.200226.53","doi-asserted-by":"publisher","DOI":"10.1038\/ng.855"},{"key":"2024102403515610000_30.159.200226.54","doi-asserted-by":"publisher","DOI":"10.1038\/ng.3520"},{"key":"2024102403515610000_30.159.200226.55","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/modpathol.2015.121","article-title":"The prognostic significance of BAP1, NF2, and CDKN2A in malignant peritoneal mesothelioma","volume":"29","author":"Singhi","year":"2016","journal-title":"Modern Pathol"},{"key":"2024102403515610000_30.159.200226.56","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2008.01.030"},{"key":"2024102403515610000_30.159.200226.57","doi-asserted-by":"crossref","first-page":"144","DOI":"10.18773\/austprescr.2011.076","article-title":"Medical management of mesothelioma","volume":"34","author":"Bowman","year":"2011","journal-title":"Aust Prescr"},{"key":"2024102403515610000_30.159.200226.58","doi-asserted-by":"publisher","DOI":"10.1097\/PAT.0b013e32835bc848"},{"key":"2024102403515610000_30.159.200226.59","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01254-2018"},{"key":"2024102403515610000_30.159.200226.60","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.lungcan.2019.05.017","article-title":"Baseline predictors of negative and incomplete pleural cytology in patients with suspected pleural malignancy \u2013 data supporting \u2018Direct to LAT\u2019 in selected groups","volume":"133","author":"Tsim","year":"2019","journal-title":"Lung Cancer"},{"key":"2024102403515610000_30.159.200226.61","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1200\/JCO.2017.76.6394","article-title":"Treatment of malignant pleural mesothelioma: American Society of Clinical Oncology clinical practice guideline","volume":"36","author":"Kindler","year":"2018","journal-title":"J Clin Oncol"},{"key":"2024102403515610000_30.159.200226.62","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00953-2019"},{"key":"2024102403515610000_30.159.200226.63","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00349-2018"},{"key":"2024102403515610000_30.159.200226.64","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.12112077"},{"key":"2024102403515610000_30.159.200226.65","doi-asserted-by":"publisher","DOI":"10.1378\/chest.14-0299"},{"key":"2024102403515610000_30.159.200226.66","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)13079-6"},{"key":"2024102403515610000_30.159.200226.67","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.chest.2019.04.090","article-title":"Confocal laser endomicroscopy as a guidance tool for pleural biopsies in malignant pleural mesothelioma","volume":"156","author":"Wijmans","year":"2019","journal-title":"Chest"},{"key":"2024102403515610000_30.159.200226.68","first-page":"Suppl. 2","article-title":"PET-CT in the undiagnosed effusion: results of the TARGET study, presented at the British Thoracic Society Winter Meeting December 4-6, 2019","volume":"74","author":"DeFonsecka","year":"2019","journal-title":"Thorax"},{"key":"2024102403515610000_30.159.200226.69","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdv199"},{"key":"2024102403515610000_30.159.200226.70","doi-asserted-by":"publisher","DOI":"10.1016\/S1010-7940(03)00609-2"},{"key":"2024102403515610000_30.159.200226.71","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5223(03)00207-1"},{"key":"2024102403515610000_30.159.200226.72","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-010-1107-z"},{"key":"2024102403515610000_30.159.200226.73","doi-asserted-by":"publisher","DOI":"10.3816\/CLC.2009.n.033"},{"key":"2024102403515610000_30.159.200226.74","doi-asserted-by":"publisher","DOI":"10.1097\/JTO.0b013e3182208e3f"},{"key":"2024102403515610000_30.159.200226.75","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.21037\/jtd.2018.02.75","article-title":"New concepts in the treatment of malignant pleural mesothelioma","volume":"10","author":"Lapidot","year":"2018","journal-title":"J Thorac Dis"},{"key":"2024102403515610000_30.159.200226.76","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(11)70149-8"},{"key":"2024102403515610000_30.159.200226.77","doi-asserted-by":"publisher","DOI":"10.1016\/j.athoracsur.2014.09.056"},{"key":"2024102403515610000_30.159.200226.78","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2013.11.026"},{"key":"2024102403515610000_30.159.200226.79","doi-asserted-by":"crossref","first-page":"7","DOI":"10.2217\/fon.15.225","article-title":"Extrapleural pneumonectomy for malignant pleural mesothelioma: is this an operation that should now be consigned to history?","volume":"11","author":"Treasure","year":"2015","journal-title":"Future Oncol"},{"key":"2024102403515610000_30.159.200226.80","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1186\/s12885-018-5064-4","article-title":"Systematic review of quality of life following pleurectomy decortication and extrapleural pneumonectomy for malignant pleural mesothelioma","volume":"18","author":"Schwartz","year":"2018","journal-title":"BMC Cancer"},{"key":"2024102403515610000_30.159.200226.81","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)60418-9"},{"key":"2024102403515610000_30.159.200226.82","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.20005.14.589"},{"key":"2024102403515610000_30.159.200226.83","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2014.08.017"},{"key":"2024102403515610000_30.159.200226.84","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.lungcan.2015.06.018","article-title":"Second line therapy in malignant pleural mesothelioma: a systematic review","volume":"89","author":"Buikhuisen","year":"2015","journal-title":"Lung Cancer"},{"key":"2024102403515610000_30.159.200226.85","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2006.09.9887"},{"key":"2024102403515610000_30.159.200226.86","doi-asserted-by":"crossref","first-page":"OA08.02","DOI":"10.1016\/j.jtho.2018.08.276","article-title":"DREAM \u2013 a phase 2 trial of durvalumab with first line chemotherapy in mesothelioma: final result","volume":"13","author":"Nowak","year":"2018","journal-title":"J Thorac Oncol"},{"key":"2024102403515610000_30.159.200226.87","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.lungcan.2015.05.021","article-title":"Research priorities in mesothelioma: a James Lind Alliance Priority Setting Partnership","volume":"89","author":"Stephens","year":"2015","journal-title":"Lung Cancer"},{"key":"2024102403515610000_30.159.200226.88","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s10147-015-0925-1","article-title":"Trimodality strategy for treating malignant pleural mesothelioma: results of a feasibility study of induction pemetrexed plus cisplatin followed by extrapleural pneumonectomy and postoperative hemithoracic radiation (Japan Mesothelioma Interest Group 0601 Trial)","volume":"21","author":"Hasegawa","year":"2016","journal-title":"Int J Clin Oncol"},{"key":"2024102403515610000_30.159.200226.89","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(15)00208-9"},{"key":"2024102403515610000_30.159.200226.90","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2013.11.004"},{"key":"2024102403515610000_30.159.200226.91","doi-asserted-by":"publisher","DOI":"10.1097\/JTO.0000000000000499"},{"key":"2024102403515610000_30.159.200226.92","doi-asserted-by":"publisher","DOI":"10.7861\/clinmedicine.13-5-452"},{"key":"2024102403515610000_30.159.200226.93","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2015.16840"},{"key":"2024102403515610000_30.159.200226.94","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1111\/resp.13755","article-title":"Clinically important associations of pleurodesis success in malignant pleural effusion: analysis of the TIME1 data set","volume":"25","author":"Mercer","year":"2020","journal-title":"Respirology"},{"key":"2024102403515610000_30.159.200226.95","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.chest.2016.11.010","article-title":"US hospitalizations for malignant pleural effusions: data from the 2012 national inpatient sample","volume":"151","author":"Taghizadeh","year":"2017","journal-title":"Chest"},{"key":"2024102403515610000_30.159.200226.96","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2012.5535"},{"key":"2024102403515610000_30.159.200226.97","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1001\/jama.2017.17426","article-title":"Effect of an indwelling pleural catheter vs talc pleurodesis on hospitalization days in patients with malignant pleural effusion: the AMPLE randomized clinical trial","volume":"318","author":"Thomas","year":"2017","journal-title":"JAMA"},{"key":"2024102403515610000_30.159.200226.98","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.lungcan.2017.01.019","article-title":"A randomized controlled trial comparing indwelling pleural catheters with talc pleurodesis (NVALT-14)","volume":"108","author":"Boshuizen","year":"2017","journal-title":"Lung Cancer"},{"key":"2024102403515610000_30.159.200226.99","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1007\/s11606-010-1472-0","article-title":"Efficacy and safety of tunneled pleural catheters in adults with malignant pleural effusions: a systematic review","volume":"26","author":"Van Meter","year":"2011","journal-title":"J Gene Intern Med"},{"key":"2024102403515610000_30.159.200226.100","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00164706"},{"key":"2024102403515610000_30.159.200226.101","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1159\/000491934","article-title":"The hospital and patient burden of indwelling pleural catheters: a retrospective case series of 210 indwelling pleural catheter insertions","volume":"97","author":"Asciak","year":"2019","journal-title":"Respiration"},{"key":"2024102403515610000_30.159.200226.102","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1055\/s-0039-1693405","article-title":"Development and maintenance of a pleural disease service: role of the \u201cpleurologist\u201d","volume":"40","author":"Cameron","year":"2019","journal-title":"Semin Respir Crit Care Med"},{"key":"2024102403515610000_30.159.200226.103","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1164\/rccm.201607-1404OC","article-title":"Randomized trial of pleural fluid drainage frequency in patients with malignant pleural effusions. The ASAP trial","volume":"195","author":"Wahidi","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"2024102403515610000_30.159.200226.104","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/S2213-2600(18)30288-1","article-title":"Aggressive versus symptom-guided drainage of malignant pleural effusion via indwelling pleural catheters (AMPLE-2): an open-label randomised trial","volume":"6","author":"Muruganandan","year":"2018","journal-title":"Lancet Respir"},{"key":"2024102403515610000_30.159.200226.105","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1056\/NEJMoa1716883","article-title":"Outpatient talc administration by indwelling pleural catheter for malignant effusion","volume":"378","author":"Bhatnagar","year":"2018","journal-title":"N Engl J Med"},{"key":"2024102403515610000_30.159.200226.106","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.lungcan.2019.09.003","article-title":"Survival in patients with malignant pleural effusion undergoing talc pleurodesis","volume":"137","author":"Hassan","year":"2019","journal-title":"Lung Cancer"},{"key":"2024102403515610000_30.159.200226.107","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2018-212380"}],"container-title":["European Respiratory Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1183\/16000617.0226-2020","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T00:02:38Z","timestamp":1740355358000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.ersnet.org\/lookup\/doi\/10.1183\/16000617.0226-2020"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,19]]},"references-count":107,"journal-issue":{"issue":"159","published-online":{"date-parts":[[2021,1,19]]},"published-print":{"date-parts":[[2021,3,31]]}},"alternative-id":["10.1183\/16000617.0226-2020"],"URL":"https:\/\/doi.org\/10.1183\/16000617.0226-2020","relation":{},"ISSN":["0905-9180","1600-0617"],"issn-type":[{"value":"0905-9180","type":"print"},{"value":"1600-0617","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,19]]}}}